Low-frequency and rare coding variants of NUS1 contribute to susceptibility and phenotype of Parkinson's disease

Neurobiol Aging. 2022 Feb:110:106-112. doi: 10.1016/j.neurobiolaging.2021.09.003. Epub 2021 Sep 17.

Abstract

NUS1 has been recently identified as a candidate gene for Parkinson's disease (PD). Few studies have examined the association of NUS1 variants with PD susceptibility and phenotypes. In the first cohort, whole-exome sequencing was performed to identify variants in NUS1 exon-coding and exon-intron regions in 1542 cases and 1625 controls. 13 variants were totally detected, of which 10 rare variants and 3 low-frequency variants. Burden analysis showed that rare NUS1 variants significantly enriched in PD (p=0.016). We also performed a meta-analysis based on previous and our studies to correlate NUS1 mutations with PD susceptibility. Integrating our previous cohort (3210 cases and 2807 controls) and the first cohort identified the significant association of rs539668656 with PD risk (odds ratio (OR) = 2.82, p = 0.016). The genotype-phenotype association analysis showed that patients carrying rare variants, or rs539668656 were significantly associated with earlier onset age, depression, emotional impairment and severe disease condition. Our results support the role of NUS1 rare variants and rs539668656 towards PD susceptibility and phenotype.

Keywords: Association study; Low frequency variants; NUS1; Parkinson’s disease; Rare variants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Cohort Studies
  • Exome Sequencing
  • Exons / genetics
  • Female
  • Gene Frequency / genetics*
  • Genetic Association Studies*
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Introns / genetics
  • Male
  • Mutation / genetics*
  • Parkinson Disease / genetics*
  • Parkinson Disease / psychology
  • Patient Acuity
  • Phenotype*
  • Receptors, Cell Surface / genetics*
  • Risk

Substances

  • NUS1 protein, human
  • Receptors, Cell Surface